Raloxifene

ATC Code G03XC01

Raloxifene

Definition

A selective benzothiophene estrogen receptor modulator (SERM). Raloxifene binds to estrogen receptors (ER) as a mixed estrogen agonist/antagonist; it displays both an ER-alpha-selective partial agonist/antagonist effect and a pure ER-beta-selective antagonist effect. This agent functions as an estrogen agonist in some tissues (bones, lipid metabolism) and as an estrogen antagonist in others (endometrium and breasts), with the potential for producing some of estrogen's beneficial effects without producing its adverse effects. (NCI04)

Also known as [6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone, Keoxifene, LY 139481, RALOXIFENE — per NCIT

Also identified as

Indications

Disease Relation Source
Postmenopausal osteoporosis may prevent MEDRT · Public domain (U.S. Government work)
Postmenopausal osteoporosis may treat MEDRT · Public domain (U.S. Government work)